These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28673022)

  • 21. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
    Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
    BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.
    Arvind B; Saxena A; Kazi DS; Bolger AF
    Indian Heart J; 2021; 73(2):169-173. PubMed ID: 33865513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.
    de Dassel JL; de Klerk N; Carapetis JR; Ralph AP
    J Am Heart Assoc; 2018 Dec; 7(24):e010223. PubMed ID: 30561268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting.
    Nkoke C; Luchuo EB; Jingi AM; Makoge C; Hamadou B; Dzudie A
    PLoS One; 2018; 13(9):e0203864. PubMed ID: 30252868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
    Haran S; Crane N; Kazi S; Axford-Haines L; White A
    Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
    Kevat PM; Reeves BM; Ruben AR; Gunnarsson R
    Curr Cardiol Rev; 2017; 13(2):155-166. PubMed ID: 28093988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RHD elimination: action needed beyond secondary prophylaxis.
    Hardie K; Ralph AP; de Dassel JL
    Aust N Z J Public Health; 2020 Oct; 44(5):427. PubMed ID: 32510810
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
    Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
    Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
    Gasse B; Baroux N; Rouchon B; Meunier JM; Frémicourt ID; D'Ortenzio E
    BMC Public Health; 2013 Feb; 13():131. PubMed ID: 23402561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever.
    Amarilyo G; Chodick G; Zalcman J; Koren G; Levinsky Y; Somekh I; Harel L
    Semin Arthritis Rheum; 2019 Jun; 48(6):1019-1024. PubMed ID: 30415945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care.
    Jamison J; Graffy J; Mullis R; Mant J; Sutton S
    Br J Gen Pract; 2016 Aug; 66(649):e568-76. PubMed ID: 27215572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India.
    Kumar R; Thakur JS; Aggarwal A; Ganguly NK
    Indian Heart J; 1997; 49(3):282-8. PubMed ID: 9291651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.
    Edwards JG; Barry M; Essam D; Elsayed M; Abdulkarim M; Elhossein BMA; Mohammed ZHA; Elnogomi A; Elfaki ASE; Elsayed A; Chang AY
    Glob Health Res Policy; 2021 Oct; 6(1):35. PubMed ID: 34598719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons to be learned: Using National Immunisation strategies to improve adherence to acute rheumatic fever secondary prophylaxis.
    Liaw JY; White AV; Gorton S; Axford-Haines L
    J Paediatr Child Health; 2019 Oct; 55(10):1170-1176. PubMed ID: 31410921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.
    Eissa S; Lee R; Binns P; Garstone G; McDonald M
    Aust N Z J Public Health; 2005 Dec; 29(6):521-5. PubMed ID: 16366062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory.
    Stewart T; McDonald R; Currie B
    Aust J Rural Health; 2007 Aug; 15(4):234-40. PubMed ID: 17617086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.
    Barker H; Oetzel JG; Scott N; Morley M; Carr PEA; Oetzel KB
    Int J Equity Health; 2017 Nov; 16(1):201. PubMed ID: 29149897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatic fever in New Zealand.
    Webb R; Wilson N
    J Paediatr Child Health; 2013 Mar; 49(3):179-84. PubMed ID: 22050578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?
    de Dassel JL; Ralph AP; Carapetis JR
    Curr Opin Pediatr; 2015 Feb; 27(1):116-23. PubMed ID: 25490689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxis.
    Talbot RG
    N Z Med J; 1984 Sep; 97(764):634-7. PubMed ID: 6591051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.